Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesCTUnderstanding CT flow artifacts is key to better disease diagnosisUnderstanding the mechanics of flow artifacts on CT or CT angiography and how these artifacts are created is key to better disease diagnosis.Molecular ImagingDual-tracer PET/CT shows promise in liver cancer patientsWomens ImagingStudies lacking for trans breast cancer screening trendsArtificial IntelligenceChatGPT performs poorly on ACR exam for residentsSponsor ContentMy BreastAI Suite by GE HealthCare
